Antonio Silvani Selected Research

Antonio Silvani Research Topics

Disease

18	Neoplasms (Cancer) 01/2021 - 05/2003
15	Glioma (Gliomas) 02/2022 - 05/2003
15	Glioblastoma (Glioblastoma Multiforme) 05/2019 - 05/2003
3	Brain Neoplasms (Brain Tumor) 01/2022 - 04/2003
3	Disease Progression 05/2019 - 08/2009
3	Neoplasm Metastasis (Metastasis) 09/2009 - 06/2008
2	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 05/2003
2	Pituitary Neoplasms (Pituitary Adenoma) 09/2018 - 06/2008
2	Epilepsy (Aura) 01/2017 - 05/2016
2	Seizures (Absence Seizure) 09/2013 - 04/2008
2	Brain Diseases (Brain Disorder) 09/2013 - 09/2009
1	Meningioma (Meningiomas) 01/2022
1	Fatigue 01/2022
1	Ketosis 01/2021
1	Prolactinoma (Prolactinomas) 09/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Parkinsonian Disorders (Parkinsonism) 05/2016
1	Nervous System Diseases (Neurological Disorders) 01/2016
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2016
1	Herpes Simplex Encephalitis (Herpes Encephalitis) 04/2015
1	Stroke (Strokes) 09/2013
1	Migraine Disorders (Migraine) 09/2013
1	Meningitis 01/2009
1	Breast Neoplasms (Breast Cancer) 06/2008
1	Thromboembolism 02/2006
1	Residual Neoplasm 04/2005
1	Germinoma 02/2005
1	Multiple Sclerosis 02/2004

Drug/Important Bio-Agent (IBA)

8	Temozolomide (Temodar)FDA LinkGeneric 09/2018 - 01/2004
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2012 - 05/2003
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 04/2008
3	Carmustine (FIVB)FDA Link 04/2013 - 08/2009
3	Mitoxantrone (Novantrone)FDA LinkGeneric 05/2008 - 04/2003
2	fotemustine (Muphoran)IBA 01/2019 - 04/2008
2	CXCR4 Receptors (CXCR4 Receptor)IBA 09/2009 - 05/2004
2	Biological ProductsIBA 09/2009 - 07/2006
2	Plasminogen Activator Inhibitor 1IBA 02/2006 - 02/2004
2	Cisplatin (Platino)FDA LinkGeneric 02/2005 - 01/2004
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	TrabectedinIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	KetonesIBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	IDN 5109 (BAY 59-8862)IBA 05/2019
1	Pharmaceutical PreparationsIBA 09/2018
1	Cabergoline FDA LinkGeneric 09/2018
1	Valproic Acid (Depakote)FDA LinkGeneric 05/2016
1	AntibodiesIBA 01/2016
1	Antimitotic AgentsIBA 12/2015
1	Conditioned Culture MediaIBA 12/2013
1	Biomarkers (Surrogate Marker)IBA 05/2012
1	poliferprosan 20 drug combination carmustine (Gliadel)FDA Link 11/2011
1	Bevacizumab (Avastin)FDA Link 11/2011
1	sagopiloneIBA 10/2009
1	Chemokine ReceptorsIBA 09/2009
1	Carcinoembryonic AntigenIBA 01/2009
1	Tumor Biomarkers (Tumor Markers)IBA 01/2009
1	EnzymesIBA 04/2008
1	Procarbazine (Matulane)FDA Link 04/2008
1	MethyltransferasesIBA 05/2007
1	DNA (Deoxyribonucleic Acid)IBA 05/2007
1	O-(6)-methylguanineIBA 05/2007
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 07/2006
1	ChemokinesIBA 07/2006
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 07/2006
1	CXCR ReceptorsIBA 07/2006
1	thiamine triphosphorate (TTP)IBA 07/2006
1	CoagulantsIBA 02/2006
1	Bleomycin (Blenoxane)FDA LinkGeneric 02/2005
1	Vinblastine (Vinblastine Sulfate)FDA Link 02/2005
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2004
1	fibrin fragment D (D-dimer)IBA 02/2004
1	Lipoprotein(a)IBA 02/2004
1	HomocysteineIBA 02/2004
1	Antineoplastic Agents (Antineoplastics)IBA 01/2004
1	O(6)-Methylguanine-DNA MethyltransferaseIBA 01/2004
1	Proteins (Proteins, Gene)FDA Link 01/2004
1	Interleukin-8 (Interleukin 8)IBA 05/2003
1	Interleukin-12 (IL 12)IBA 05/2003

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 01/2018 - 02/2005
10	Radiotherapy 07/2017 - 02/2005
7	Therapeutics 01/2022 - 04/2008
3	Chemoradiotherapy 12/2015 - 11/2011
2	Aftercare (After-Treatment) 02/2022 - 11/2021
2	Re-Irradiation 08/2015 - 06/2015
1	Ketogenic Diet 01/2021
1	Combined Modality Therapy 09/2018
1	Transplantation 04/2015
1	Drug Tapering 08/2009
1	Radioimmunotherapy 04/2005
1	Immunotherapy 04/2005
1	Neoadjuvant Therapy 02/2005